Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.17.3.498PMID 9102168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages.

  1996cited by this paper
• Purification of the human THP-1 monocyte-macrophage triglyceride-rich lipoprotein receptor.

  1995cited by this paper
• Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice.

  1995cited by this paper
• Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

  1995cited by this paper
• Human THP-1 monocyte-macrophage membrane binding proteins: distinct receptor(s) for triglyceride-rich lipoproteins.

  1995cited by this paper
• Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3.

  1994cited by this paper
• Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice.

  1994cited by this paper
• ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.

  1994cited by this paper
• ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

  1994cited by this paper
• Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice.

  1994cited by this paper
• Cellular binding site and membrane binding proteins for triglyceride-rich lipoproteins in human monocyte-macrophages and THP-1 monocytic cells.

  1994cited by this paper
• Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins.

  1994cited by this paper
• Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

  1994cited by this paper
• Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.

  1993cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins.

  1992cited by this paper
• Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.

  1992cited by this paper
• Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques.

  1992cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages.

  1992cited by this paper
• Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

  1991cited by this paper
• Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions.

  1991cited by this paper
• The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2.

  1991cited by this paper
• Synthetic low and high fat diets for the study of atherosclerosis in the mouse.

  1990cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.

  1988cited by this paper
• Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

  1987cited by this paper
• Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity.

  1987cited by this paper
• A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.

  1987cited by this paper
• Familial apolipoprotein E deficiency.

  1986cited by this paper
• The metabolism in vitro of human low-density lipoprotein by the human hepatoma cell line Hep G2.

  1983cited by this paper
• Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment

  1983cited by this paper
• Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes

  1983cited by this paper
• NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment.

  1983cited by this paper
• Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.

  1981cited by this paper
• Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

  1976cited by this paper
• Separation of plasma lipoproteins by density-gradient ultracentrifugation.

  1975cited by this paper
• The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

  1972cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Lipoprotein lipase: Biosynthesis, regulatory factors, and its role in atherosclerosis and other diseases.

  2018cites this paper
• The effects of triglyceride on lysosomal function in macrophage foam cells

  2009cites this paper
• Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathwayss⃞ Published, JLR Papers in Press, December 5, 2006.

  2007cites this paper
• Formation of ceramide‐enriched domains in lipid particles enhances the binding of apolipoprotein E

  2005cites this paper
• Low-Density Lipoprotein From Apolipoprotein E–Deficient Mice Induces Macrophage Lipid Accumulation in a CD36 and Scavenger Receptor Class A–Dependent Manner

  2004cites this paper
• Chimeras of lipoprotein lipase and hepatic lipase : localization of the apolipoprotein C-II activation site of lipoprotein lipase

  2003cites this paper
• The murine macrophage apoB-48 receptor gene (Apob-48r): homology to the human receptor.

  2002cites this paper
• Peroxisome proliferator‐activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages

  2002cites this paper
• Macrophage foam cells and atherosclerosis.

  2001cites this paper
• The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages.

  2001cites this paper
• Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.

  2000cites this paper
• Sphingomyelinase Converts Lipoproteins From Apolipoprotein E Knockout Mice Into Potent Inducers of Macrophage Foam Cell Formation

  2000cites this paper
• Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins.

  1999cites this paper
• Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix.

  1999cites this paper
• Pathophysiology of triglyceride‐rich lipoproteins in atherothrombosis: Cellular aspects

  1999cites this paper
• Macrophage specific overexpression of the human macrophage scavenger receptor in transgenic mice, using a 180-kb yeast artificial chromosome, leads to enhanced foam cell formation of isolated peritoneal macrophages.

  1999cites this paper
• Nonoxidative modifications of lipoproteins in atherogenesis.

  1999cites this paper
• Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.

  1999cites this paper
• Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (op) and apolipoprotein E.

  1998cites this paper
• Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages.

  1998cites this paper
• Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis.

  1998cites this paper
• The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway.

  1998cites this paper
• Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.

  1998cites this paper
• Triglyceride-rich Remnant Lipoproteins Detection, Quantification, and Characterization of Potentially Atherogenic

  year unknowncites this paper